Ron Chiarello

Chief Executive Officer at 54Gene, Inc.

Health Technology

Profile

Ron Chiarello was the founder of Alveo Technologies, Inc., which was founded in 2014, where he held the title of Chairman & Chief Executive Officer.
Currently, he is the Chief Executive Officer at 54Gene, Inc. where he started in 2023 and is still active.

Ron Chiarello active positions

Companies	Position	Start
54Gene, Inc. 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023.	Chief Executive Officer	2023-03-14

All active positions of Ron Chiarello

Former positions of Ron Chiarello

Companies	Position	End
Alveo Technologies, Inc. Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA.	Chief Executive Officer	2022-11-16

See the detail of Ron Chiarello's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ron Chiarello's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Alveo Technologies, Inc. Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA.	Health Technology
54Gene, Inc. 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023.	Health Technology